Cargando…

Do Toll-like Receptors Play a New Role as a Biomarker of Irritable Bowel Syndrome?

Detalles Bibliográficos
Autor principal:	Kim, Hyun Jin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society of Neurogastroenterology and Motility 2018
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6175550/ https://www.ncbi.nlm.nih.gov/pubmed/30347933 http://dx.doi.org/10.5056/jnm18153

Ejemplares similares

Does the Microbiota Play a Pivotal Role in the Pathogenesis of Irritable Bowel Syndrome?
por: Fagoonee, Sharmila, et al.
Publicado: (2019)

Role of Toll Like Receptors in Irritable Bowel Syndrome: Differential Mucosal Immune Activation According to the Disease Subtype
por: Belmonte, Liliana, et al.
Publicado: (2012)

Irritable Bowel Syndrome
por: Farup, Per G., et al.
Publicado: (2012)

Epidemiology of irritable bowel syndrome
por: Endo, Yuka, et al.
Publicado: (2015)

Irritable Bowel Syndrome and Synbiotics
por: Kim, Soo Young
Publicado: (2019)

Irritable Bowel Syndrome and Antidepressants
por: Curtiss, Frederic R.
Publicado: (2008)

Role of Fructose Malabsorption in Patients With Irritable Bowel Syndrome
por: Kim, Young, et al.
Publicado: (2018)

Increased Expression of Toll-Like Receptors 4, 5, and 9 in Small Bowel Mucosa from Patients with Irritable Bowel Syndrome
por: Dlugosz, Aldona, et al.
Publicado: (2017)

Why Do Irritable Bowel Syndrome Women Often Have Nausea Symptom?
por: Chang, Full-Young
Publicado: (2012)

From Cytokines to Toll-Like Receptors and Beyond - Current Knowledge and Future Research Needs in Irritable Bowel Syndrome
por: Rodríguez-Fandiño, Oscar, et al.
Publicado: (2010)

Decreased Neuroplasticity May Play a Role in Irritable Bowel Syndrome: Implication From the Comorbidity of Depression and Irritable Bowel Syndrome
por: Zheng, Zhihua, et al.
Publicado: (2015)

Biomarkers of Irritable Bowel Syndrome
por: Kim, Jae Hak, et al.
Publicado: (2017)

Fructose Malabsorption in Patients With Irritable Bowel Syndrome-like Symptoms: What Is the Role in the Pathogenesis and Clinical Implication?
por: Sung, Hye-Young, et al.
Publicado: (2014)

Modulation of inflammation by toll-like receptor 4/nuclear factor-kappa B in diarrhea-predominant irritable bowel syndrome
por: He, Xing, et al.
Publicado: (2017)

Pathophysiological Commonality Between Irritable Bowel Syndrome and Metabolic Syndrome: Role of Corticotropin-releasing Factor–Toll-like Receptor 4–Proinflammatory Cytokine Signaling
por: Nozu, Tsukasa, et al.
Publicado: (2022)

Diagnosis of Irritable Bowel Syndrome: Role of Potential Biomarkers
por: Plavšić, Ivana, et al.
Publicado: (2015)

The Role of Small Intestinal Bacterial Overgrowth in the Pathophysiology of Irritable Bowel Syndrome
por: Park, Hyojin
Publicado: (2010)

Possible therapeutic role of IgE blockade in irritable bowel syndrome
por: Magen, Eli, et al.
Publicado: (2016)

Acute kidney injury: what part do toll-like receptors play?
por: Vallés, Patricia G, et al.
Publicado: (2014)

Are probiotics effective in management of irritable bowel syndrome?
por: Hosseini, Asieh, et al.
Publicado: (2012)

Prevalence of Irritable Bowel Syndrome in Northern India
por: Chua, Andrew Seng Boon
Publicado: (2011)

Pathogenesis of Irritable Bowel Syndrome: Is It Really in the Gene?
por: Ghoshal, Uday C, et al.
Publicado: (2014)

A Distinct Profile of Tryptophan Metabolism along the Kynurenine Pathway Downstream of Toll-Like Receptor Activation in Irritable Bowel Syndrome
por: Clarke, Gerard, et al.
Publicado: (2012)

Serum biomarkers for irritable bowel syndrome
por: CHIRA, ALEXANDRA, et al.
Publicado: (2015)

Do Socio-Demographics Play a Role in the Prevalence of Red Flags and Pursuant Colonoscopies in Patients With Irritable Bowel Syndrome?
por: Mittal, Anmol, et al.
Publicado: (2022)

Defining the irritable bowel
por: Chuah, Kee Huat, et al.
Publicado: (2022)

Irritable bowel syndrome: Is it “irritable brain” or “irritable bowel”?
por: Padhy, Susanta Kumar, et al.
Publicado: (2015)

Prevalence and Risk Factors of Irritable Bowel Syndrome in Asia
por: Lee, Oh Young
Publicado: (2010)

Treatment of irritable bowel syndrome with probiotics: growing evidence
por: Bixquert, Miguel
Publicado: (2013)

Irritable bowel syndrome: What physicians should know?
por: Oshima, Tadayuki, et al.
Publicado: (2015)

Dysregulated MicroRNA Expression in Irritable Bowel Syndrome
por: Park, Jung Ho
Publicado: (2016)

Toll-Like Receptor mRNA Expression Is Selectively Increased in the Colonic Mucosa of Two Animal Models Relevant to Irritable Bowel Syndrome
por: McKernan, Declan P., et al.
Publicado: (2009)

Corticotropin-Releasing Factor and Toll-Like Receptor Gene Expression Is Associated with Low-Grade Inflammation in Irritable Bowel Syndrome Patients with Depression
por: Jizhong, Song, et al.
Publicado: (2016)

Toll-Like Receptors and RIG-I-Like Receptors Play Important Roles in Resisting Flavivirus
por: Guo, Hong-Yan, et al.
Publicado: (2018)

Irritable Inflammatory Bowel Syndrome as a Distinct Disease Entity
por: Oh, Jung Hwan
Publicado: (2016)

Antispasmodics in irritable bowel syndrome – a hoary old chestnut?
por: Pietrzak, Anna
Publicado: (2021)

Irritable Bowel Syndrome: A Multifaceted World Still to Discover
por: Bassotti, Gabrio
Publicado: (2022)

Irritable Bowel Syndrome or Psychiatric Disorders: Which Comes First?
por: Lee, Hong Sub
Publicado: (2022)

Current Status of Diagnosis and Treatment of Irritable Bowel Syndrome in Korea
por: Kim, You Sun
Publicado: (2023)

Toll-like Receptors and Inflammatory Bowel Disease
por: Lu, Yue, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_biin9la3quu5j5j10cssntk2r1